Innovative Technology Solutions to Cancer Sample Preparation (SBIR [R43/R44])
The summary for the Innovative Technology Solutions to Cancer Sample Preparation (SBIR [R43/R44]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Technology Solutions to Cancer Sample Preparation (SBIR [R43/R44]): Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI) solicits grant applications from small business concerns (SBCs) that propose research projects focused on the development and/or application of innovative technologies addressing various aspects of the preparation, purification, processing, and handling of cancer-relevant samples. The overall goal is to develop technologies that maximize the quality and utility of biospecimens for molecular analyses of cancer cells and their host environments without compromising donor/patient health. This FOA will also support the development of methods and tools to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control under diverse conditions. Responsive technologies encompass relevant methods, techniques, tools, instrumentation, and devices (but not software or informatics solutions). The proposed development of cancer sample-preparation technologies must reflect the intent to ultimately commercialize these technologies. This FOA is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs. See NOT-CA-08-003.
Federal Grant Title: | Innovative Technology Solutions to Cancer Sample Preparation (SBIR [R43/R44]) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-CA-08-013 |
Type of Funding: | Grant |
CFDA Numbers: | 93.39293.393 |
CFDA Descriptions: | Cancer Construction 93.393 Cancer Cause and Prevention Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Sep 24, 2008 |
Posted Date: | Jan 09, 2008 |
Creation Date: | Jan 09, 2008 |
Archive Date: | Oct 25, 2008 |
Total Program Funding: | $1,250,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | 93.394 -- Cancer Detection and Diagnosis Research |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster